Experimental vaccine fails to protect babies against TB

02/4/2013 | Medical News Today

The MVA85A vaccine has been developed to boost the immune responses of the Bacille Calmette-Guérin vaccine against tuberculosis, but a trial in South Africa found that the experimental vaccine was not as effective in babies as it has been shown to be in adults. The vaccine's efficacy rate of 17.3% was not statistically significant, researchers reported in The Lancet.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC